Recalls, reimbursement, remote data & referrals all changing the landscape
Noninvasive Ventilation
BOTHELL, Wash. (September 23, 2021)—Ventec Life Systems, a global medical device company focused on redefining respiratory care technologies for patients and caregivers, announced today that the standalone V+Pro ventilator was added to the Pricing, Data Analysis and Coding (PDAC) Product Classification List (PCL) under the Health Care Procedure Coding System (HCPCS) as reimbursable under codes E0465 or E0466.
LIVINGSTON, Tenn. (June 11, 2021)—Encore Healthcare announced the results from their new oxygen and nebulizer management Nexus TeleRespiratory Care model. Encore used over 20 million data points from chronic respiratory failure patients on home ventilation to build a predictive model that allows home medical equipment (HME) providers to identify when patients need services before they end up in the hospital multiple times.
NORTH BILLERICA, Mass. (February 10, 2021)—Breas Medical USA is proud to announce the market introduction of the Vivo 45 LS, one of the smallest, full-featured life support devices on the market.
WASHINGTON, D.C. (September 24, 2020)—In a recent audit from the Department of Health and Human Services Office of Inspector General (OIG), the department found a 52% increase in Medicare-allowed charges on noninvasive ventilators (NIVs) between 2016 and 2018.
The Safeguarding Medicare Access to Respiratory Therapy Act of 2019
WASHINGTON, D.C. (November 13, 2019)––The Council for Quality Respiratory Care (CQRC)—a coalition of the nation's leading home oxygen therapy provider and manufacturing companies—commends a bipartisan bill recently introduced in the House of Representatives that will help ensure America’s most vulnerable respiratory patients receive uninterrupted access to the non-invasive ventilators (NIV) they need to live.
Research in noninvasive ventilation for COPD treatment.
NEW YORK (February 12, 2018)—Jeremy Orr, MD, of University of California, San Diego, has been awarded the new ATS Foundation/ResMed Research Fellowship in Noninvasive Ventilation (NIV) in COPD.
ResMed is a provider of NIV devices for treating COPD (chronic obstructive pulmonary disease) in the home and hospital.
Dr. Orr’s $100,000 award will support his research focused on the impact of noninvasive ventilation on cardiovascular biomarkers in COPD.
Philips study shows 92 percent of patients are not receiving PAP therapy.
TUCSON, Ariz. (July 10, 2017)—COPD hospitalizations are at an all-time high. The 30-day readmission rate for patients ranges from 20 to 39 percent, with related health care costs at an estimated $50 billion. A recently published study, funded by Royal Philips, revealed that although positive airway pressure (PAP) therapy was associated with a reduction in hospitalization, more than 92 percent of patients studied were not receiving it in any form.
AMSTERDAM (June 16, 2016)—Philips Respironics, a business of Royal Philips, introduced the Wisp Pediatric Nasal Mask, which supports non-invasive ventilation (NIV) and is the most recent addition to the Wisp family of masks. Designed specifically for children, the Wisp Pediatric Nasal Mask features a child-friendly giraffe fabric pattern, a modified cushion curvature and support tools to help provide a positive experience for young patients and their families.